Menu

Close

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs

Kale Kundert, James E Lucas, Kyle E Watters, Christof Fellmann, Andrew H Ng, Benjamin M Heineike, Christina M Fitzsimmons, Benjamin L Oakes, David F Savage, Hana El-Samad, Jennifer A Doudna, Tanja Kortemme

Preprint posted on May 15, 2018 https://www.biorxiv.org/content/early/2018/05/15/323105

A recent preprint highlights an advance in CRISPR/Cas9 technology that would enable the independent regulation of different target genes in the same cell.

Selected by Samantha Seah

Summary

Utilising ligands to activate or deactivate sgRNAs provides a new way to regulate CRISPR-Cas9 activity in a dose-dependent manner, enabling manipulations to be carried out on different targets within the same cell.

 

Background

The CRISPR/Cas9 system almost needs no introduction – its ease of use has made it the most attractive system for genetic engineering today. The Cas9 nuclease is targeted to specific sites in the genome by the introduction of single guide RNAs (sgRNAs) complementary to the site of interest, enabling precise DNA cleavage that can be utilised to generate gene knockouts or knock-ins. Alternatively, the inactivation of both Cas9 nuclease domains and coupling to an enzymatic domain, such as to an activation domain or epigenetic modifier, enables the specific targeting of enzymatic activities to exact genomic coordinates. Similarly, the inactivated Cas9 protein (dCas9) is able to sterically repress transcription.  Previous adaptations made to control CRISPR/Cas9 activity largely target Cas9 activity using chemical or optical inputs, which modulates all gene targets in the same direction. It is also possible to use multiple orthogonal CRISPR-Cas9 systems to modulate different targets in different directions. A key limitation of the CRISPR/Cas technology is the potential for off-target effects, which may introduce unwanted effects and limits the use of CRISPR-Cas9 in therapeutics.

 

Key Findings

The authors demonstrate the use of ligands to activate or deactivate sgRNA, and thus CRISPR/Cas9. This was carried out by the addition of ligand-binding aptamers to the sgRNAs utilised. By choosing to target sgRNAs, which vary between different targets, different manipulations can be carried out on different targets within the same cell.

Here, the authors chose to use the well-characterised small molecule, theophylline, and its corresponding aptamer, to establish the system. They tested three different strategies to link the aptamer to sgRNA, and eventually found that strand displacement, using sequences that enable alternative base pairing in the ligand-bound and ligand-free states, was most successful strategy. Multiple designs were responsive to theophylline in vitro, and these included designs that were activated or deactivated by the addition of theophylline. Utilising CRISPR-Cas9-mediated repression of fluorescent protein expression, they showed that the ligand-activated and inactivated sgRNAs had up to 11x and 13x dynamic ranges respectively, spanning over 50% of the range achieved by the controls. These sgRNAs also responded to changing concentrations of theophylline in a dose-dependent manner, suggesting that these sgRNAs could be used to precisely modulate gene expression.

The authors even utilised a second, related ligand-aptamer pair. The 3-methylxanthine (3mx) aptamer differs from that of theophylline by a single base-pair, and even as the theophylline aptamer is recognised by both ligands, the 3-methylxanthine aptamer only responds to its ligand, 3mx. They were then able to establish a system with two different fluorescent proteins under the control of different ligand-aptamer pairs, and demonstrated that fluorescent protein expression can be logically and temporally regulated by sequential addition and removal of the two ligands.

Figure 1a from the preprint: Principles of the technology. Small molecule aptamers are inserted into sgRNAs, resulting in the stabilisation of functional CRISPR-Cas9-sgRNA complexes either in the presence (above) or absence (below) of the ligand.

 

What I like about this work

I find the principles of this modification of CRISPR/Cas9 technology extremely elegant. By regulating individual sgRNAs, target genes can be independently modulated. The fact that they found both ligand activated and deactivated sgRNAs suggests that different genes can be regulated in opposite directions with a single ligand.

 

Outlook

The authors have established this system in bacteria cells, and it would be interesting to see if similar systems could be adapted for use in mammalian cells. The authors attempted this in both yeast and mammalian systems, and it did not appear to convincingly work in either. In addition, higher concentrations of theophylline was toxic to mammalian cells. It appears that alternative ligand-aptamer systems might be required to transfer this technology into eukaryotic cells.

(To the authors: Do you have any idea why the system did not appear to work in the eukaryotic cells tested? Do you have any idea how you might overcome this, to transfer the technology into eukaryotic cells?)

In addition, the availability of a variety of ligand-aptamer pairs that can act independently of each other would be ideal. Scientists could then pick and test ligand-aptamer pairs that suit their purposes.

Off-target effects are often problematic in CRISPR/Cas9 applications, and one way to minimise off-target effects is to only have Cas9 expressed for extremely short time periods. It would be interesting to see if this technology could be coupled with transient transfection to further minimise off-target effects.

Tags: crispr-cas, crispri

Posted on: 14th June 2018

Read preprint (No Ratings Yet)




  • Have your say

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Sign up to customise the site to your preferences and to receive alerts

    Register here

    Also in the molecular biology category:

    MRE11-RAD50-NBS1 activates Fanconi Anemia R-loop suppression at transcription-replication conflicts

    Emily Yun-Chia Chang, James P Wells, Shu-Huei Tsai, et al.



    Selected by Katie Weiner

    1

    Super-resolution Molecular Map of Basal Foot Reveals Novel Cilium in Airway Multiciliated Cells

    Quynh Nguyen, Zhen Liu, Rashmi Nanjundappa, et al.



    Selected by Robert Mahen

    Atlas of Subcellular RNA Localization Revealed by APEX-seq

    Furqan M Fazal, Shuo Han, Pornchai Kaewsapsak, et al.

    AND

    Proximity RNA labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules

    Alejandro Padron, Shintaro Iwasaki, Nicholas Ingolia



    Selected by Christian Bates

    Unlimited genetic switches for cell-type specific manipulation

    Jorge Garcia-Marques, Ching-Po Yang, Isabel Espinosa-Medina, et al.



    Selected by Rafael Almeida

    1

    Stable knockout and complementation of receptor expression using in vitro cell line derived reticulocytes for dissection of host malaria invasion requirements

    Timothy J Satchwell, Katherine E Wright, Katy L Haydn-Smith, et al.



    Selected by Alyson Smith

    The coordination of terminal differentiation and cell cycle exit is mediated through the regulation of chromatin accessibility

    Yiqin Ma, Daniel J McKay, Laura Buttitta



    Selected by Gabriel Aughey

    1

    Disrupting Transcriptional Feedback Yields an Escape-Resistant Antiviral

    Sonali Chaturvedi, Marie Wolf, Noam Vardi, et al.



    Selected by Pavithran Ravindran

    1

    Multi-color single molecule imaging uncovers extensive heterogeneity in mRNA decoding

    Sanne Boersma, Deepak Khuperkar, Bram M.P. Verhagen, et al.



    Selected by Lorenzo Lafranchi

    Multi-color single molecule imaging uncovers extensive heterogeneity in mRNA decoding

    Sanne Boersma, Deepak Khuperkar, Bram M.P. Verhagen, et al.

    AND

    Live-cell single RNA imaging reveals bursts of translational frameshifting

    Kenneth R Lyon Jr, Luis U Aguilera, Tatsuya Morisaki, et al.



    Selected by Nicola Stevenson

    A non-canonical arm of UPRER mediates longevity through ER remodeling and lipophagy.

    Joseph R Daniele, Ryo Higuchi-Sanabria, Vidhya Ramachandran, et al.



    Selected by Sandra Malmgren Hill

    Retrieving High-Resolution Information from Disordered 2D Crystals by Single Particle Cryo-EM

    Ricardo Righetto, Nikhil Biyani, Julia Kowal, et al.



    Selected by David Wright

    The modular mechanism of chromocenter formation in Drosophila

    Madhav Jagannathan, Ryan Cummings, Yukiko M Yamashita



    Selected by Maiko Kitaoka

    1

    The structural basis for release factor activation during translation termination revealed by time-resolved cryogenic electron microscopy

    Ziao Fu, Gabriele Indrisiunaite, Sandip Kaledhonkar, et al.



    Selected by David Wright

    The cell wall regulates dynamics and size of plasma-membrane nanodomains in Arabidopsis.

    Joseph Franics McKenna, Daniel Rolfe, Stephen E D Webb, et al.



    Selected by Marc Somssich

    Psychiatric risk gene NT5C2 regulates protein translation in human neural progenitor cells

    Rodrigo R.R. Duarte, Nathaniel D. Bachtel, Marie-Caroline Cotel, et al.



    Selected by Joanna Cross

    DNA microscopy: Optics-free spatio-genetic imaging by a stand-alone chemical reaction

    Joshua A. Weinstein, Aviv Regev, Feng Zhang



    Selected by Theo Sanderson

    2

    Close